Sun-Wei Guo Joins Foraviset’s Scientific Advisory Board – Foraviset
Foraviset shared a post on LinkedIn:
“We are thrilled and honored to announce that Prof. Sun-Wei Guo, Professor of Gynecology at Shanghai OB/GYN Hospital, Fudan University, has joined Foraviset’s Scientific Advisory Board.
It’s difficult to capture Prof. Guo’s career in a single post – but a few highlights speak for themselves.
Prof. Guo is ranked by Stanford University among the world’s Top 2% scientists.
After receiving his PhD from the University of Washington in 1991, he held senior research and academic positions across leading U.S. and Chinese institutions, including the University of Michigan, University of Minnesota, the Medical College of Wisconsin, and Shanghai Jiao Tong University.
He has served on the boards of the World Endometriosis Society (WES) and SEUD, and is one of the Founders, Board Member, and former President of the Asian Society of Endometriosis and Adenomyosis (ASEA).
Prof. Guo currently sits on the Scientific Advisory Board of the Endometriosis Foundation of America, and serves on the International Advisory Board of the Taiwan Endometriosis Society.
His editorial leadership is distinguished, no less:
Prof. Guo is Co-Editor-in-Chief of the Journal of Endometriosis and Uterine Disorders, and serves as Associate Editor for Human Reproduction Open and Reproduction and Fertility, alongside multiple editorial board roles. He is also the former Associate Editor for several high-impact journals, including Human Reproduction Update, Reproductive Sciences, and Gynecology and Minimally Invasive Therapy.
As a member of Foraviset’s Scientific Advisory Board, Prof. Guo will provide strategic scientific and clinical guidance, support trial readiness and long-term positioning, and help strengthen the academic rigor underpinning our non-hormonal approach to uterine health.
We are proud to welcome Prof. Guo to Foraviset at this pivotal stage of our journey.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting
-
Jan 12, 2026, 13:14Lucile Ferreux: Prenatal Cadmium Exposure and Its Long-Term Impact on Male Fertility
-
Jan 12, 2026, 13:11This Month’s Fertility and Sterility Unplugged Is Live – Fertility and Sterility
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:58Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
-
Jan 11, 2026, 09:56Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths